Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Antimicrobial Agents and Chemotherapy|August 13, 2024
Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolatesOriana Kreutzfeld, Stephen Orena, Martin Okitwi, et al.
The Lancet. Microbe|September 23, 2021
Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic studyPatrick K Tumwebaze, Thomas Katairo, Martin Okitwi, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2021
Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum IsolatesOriana Kreutzfeld, Stephanie A Rasmussen, Aarti A Ramanathan, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2015
Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan childrenPatrick Tumwebaze, Melissa D Conrad, Andrew Walakira, et al.
PLOS Global Public Health|March 24, 2023
House design and risk of malaria, acute respiratory infection and gastrointestinal illness in Uganda: A cohort studyAlex K Musiime, Paul J Krezanoski, David L Smith, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2022
Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome InhibitorsShreeya Garg, Oriana Kreutzfeld, Sevil Chelebieva, et al.
Microbiology Spectrum|May 9, 2023
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug PipelineOriana Kreutzfeld, Patrick K Tumwebaze, Martin Okitwi, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2024
The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolatesMartin Okitwi, Douglas A Shoue, Lisa A Checkley, et al.
Pageof 30